Products

Buprenorphine base
Buprenorphine hydrochloride
Buprenorphine intermediate
Codeine Phosphate (Q2 2017)
Dexamfetamine (as bisulphate) (Q1 2017)
Hydromorphone hydrochloride
Lisdexamfetamine (as di-mesylate) (Q4 2016)
Pramipexole dihydrochloride monohydrate
(R)-5-(2-Aminopropyl)-2-methoxybenzenesulfonamide (Tamsulosine intermediat)
Risedronate sodium
Terbinafine hydrochloride
Tolfenamic acid

Samples for R&D use in the United States are available as permitted under 35 USC § 271 (e)(1). Product currently under patent protection could be available only for R&D purposes, if this is allowed by local laws. Products covered by valid patents in any country are not offered or supplied to these countries for commercial use. However, the final responsibility lies exclusively on the buyer.